vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and REPUBLIC BANCORP INC (RBCAA). Click either name above to swap in a different company.

REPUBLIC BANCORP INC is the larger business by last-quarter revenue ($94.3M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 5.3%). REPUBLIC BANCORP INC produced more free cash flow last quarter ($161.1M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -11.5%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Republic Bancorp Inc. (Kentucky) is a U.S. regional banking holding company that provides a full range of retail and commercial banking services, including personal deposit accounts, consumer loans, business financing, mortgage products, and wealth management solutions. It mainly serves individual consumers and small to medium-sized enterprises in Kentucky and adjacent U.S. states.

PBYI vs RBCAA — Head-to-Head

Bigger by revenue
RBCAA
RBCAA
1.2× larger
RBCAA
$94.3M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+22.4% gap
PBYI
27.7%
5.3%
RBCAA
More free cash flow
RBCAA
RBCAA
$146.7M more FCF
RBCAA
$161.1M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-11.5%
RBCAA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
RBCAA
RBCAA
Revenue
$75.5M
$94.3M
Net Profit
$22.8M
Gross Margin
69.3%
Operating Margin
22.7%
29.3%
Net Margin
24.2%
Revenue YoY
27.7%
5.3%
Net Profit YoY
20.0%
EPS (diluted)
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
RBCAA
RBCAA
Q4 25
$75.5M
$94.3M
Q3 25
$54.5M
$93.5M
Q2 25
$52.4M
$93.8M
Q1 25
$46.0M
$135.8M
Q4 24
$59.1M
$89.5M
Q3 24
$80.5M
$88.1M
Q2 24
$47.1M
$86.9M
Q1 24
$43.8M
$120.3M
Net Profit
PBYI
PBYI
RBCAA
RBCAA
Q4 25
$22.8M
Q3 25
$8.8M
$29.7M
Q2 25
$5.9M
$31.5M
Q1 25
$3.0M
$47.3M
Q4 24
$19.0M
Q3 24
$20.3M
$26.5M
Q2 24
$-4.5M
$25.2M
Q1 24
$-4.8M
$30.6M
Gross Margin
PBYI
PBYI
RBCAA
RBCAA
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
PBYI
PBYI
RBCAA
RBCAA
Q4 25
22.7%
29.3%
Q3 25
17.6%
40.4%
Q2 25
12.7%
43.0%
Q1 25
8.7%
44.1%
Q4 24
22.6%
25.8%
Q3 24
27.4%
38.4%
Q2 24
-4.6%
37.0%
Q1 24
-5.3%
32.2%
Net Margin
PBYI
PBYI
RBCAA
RBCAA
Q4 25
24.2%
Q3 25
16.2%
31.8%
Q2 25
11.2%
33.5%
Q1 25
6.5%
34.8%
Q4 24
21.2%
Q3 24
25.2%
30.1%
Q2 24
-9.6%
29.0%
Q1 24
-11.0%
25.4%
EPS (diluted)
PBYI
PBYI
RBCAA
RBCAA
Q4 25
$0.26
Q3 25
$0.17
Q2 25
$0.12
Q1 25
$0.06
Q4 24
$0.40
Q3 24
$0.41
Q2 24
$-0.09
Q1 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
RBCAA
RBCAA
Cash + ST InvestmentsLiquidity on hand
$97.5M
$220.0M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$1.1B
Total Assets
$216.3M
$7.0B
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
RBCAA
RBCAA
Q4 25
$97.5M
$220.0M
Q3 25
$94.4M
$484.2M
Q2 25
$96.0M
$484.8M
Q1 25
$93.2M
$793.0M
Q4 24
$101.0M
$432.2M
Q3 24
$96.7M
$530.9M
Q2 24
$96.8M
$400.1M
Q1 24
$107.2M
$546.4M
Total Debt
PBYI
PBYI
RBCAA
RBCAA
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
RBCAA
RBCAA
Q4 25
$130.3M
$1.1B
Q3 25
$115.3M
$1.1B
Q2 25
$104.7M
$1.1B
Q1 25
$97.1M
$1.0B
Q4 24
$92.1M
$992.0M
Q3 24
$71.1M
$979.7M
Q2 24
$48.5M
$955.4M
Q1 24
$51.0M
$935.6M
Total Assets
PBYI
PBYI
RBCAA
RBCAA
Q4 25
$216.3M
$7.0B
Q3 25
$202.9M
$7.0B
Q2 25
$194.9M
$7.0B
Q1 25
$196.2M
$7.1B
Q4 24
$213.3M
$6.8B
Q3 24
$220.7M
$6.7B
Q2 24
$205.0M
$6.6B
Q1 24
$214.1M
$6.9B
Debt / Equity
PBYI
PBYI
RBCAA
RBCAA
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
RBCAA
RBCAA
Operating Cash FlowLast quarter
$14.4M
$168.2M
Free Cash FlowOCF − Capex
$14.4M
$161.1M
FCF MarginFCF / Revenue
19.1%
170.9%
Capex IntensityCapex / Revenue
0.0%
7.5%
Cash ConversionOCF / Net Profit
7.37×
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$288.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
RBCAA
RBCAA
Q4 25
$14.4M
$168.2M
Q3 25
$9.7M
$33.3M
Q2 25
$14.1M
$8.4M
Q1 25
$3.6M
$93.2M
Q4 24
$15.6M
$149.0M
Q3 24
$11.0M
$51.3M
Q2 24
$1.0M
$4.0M
Q1 24
$11.2M
$71.2M
Free Cash Flow
PBYI
PBYI
RBCAA
RBCAA
Q4 25
$14.4M
$161.1M
Q3 25
$9.7M
$30.8M
Q2 25
$14.1M
$5.2M
Q1 25
$3.6M
$91.6M
Q4 24
$15.6M
$143.2M
Q3 24
$11.0M
$49.8M
Q2 24
$1.0M
$2.7M
Q1 24
$69.1M
FCF Margin
PBYI
PBYI
RBCAA
RBCAA
Q4 25
19.1%
170.9%
Q3 25
17.7%
32.9%
Q2 25
26.8%
5.5%
Q1 25
7.7%
67.4%
Q4 24
26.4%
160.0%
Q3 24
13.7%
56.5%
Q2 24
2.1%
3.1%
Q1 24
57.5%
Capex Intensity
PBYI
PBYI
RBCAA
RBCAA
Q4 25
0.0%
7.5%
Q3 25
0.0%
2.6%
Q2 25
0.0%
3.5%
Q1 25
0.1%
1.2%
Q4 24
0.0%
6.5%
Q3 24
0.0%
1.7%
Q2 24
0.0%
1.5%
Q1 24
0.0%
1.7%
Cash Conversion
PBYI
PBYI
RBCAA
RBCAA
Q4 25
7.37×
Q3 25
1.10×
1.12×
Q2 25
2.41×
0.27×
Q1 25
1.21×
1.97×
Q4 24
7.84×
Q3 24
0.54×
1.93×
Q2 24
0.16×
Q1 24
2.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons